• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Anti-EBV Drug Under Development at Wistar Institute

Gemini

Gemini

Senior Member
Messages
1,176
Location
East Coast USA
Wistar Institute researchers homing in on a novel anti-EBV drug that disables the EBNA1 protein received a three-year $5.6 million grant from the U.K. based Wellcome Trust...
http://www.eurekalert.org/pub_releases/2015-05/twi-wr051915.php

Targeting EBV related cancers, researchers believe it may also have value for diseases like MS and mono.

They've met with the FDA to discuss the design of human trials expected to begin in 2018.

If initial trials succeed they'll look for a pharmaceutical company to underwrite final trials.

Sounds encouraging...
 
You must log in or register to reply here.